John Paulson Horizon Therapeutics Public LTD CO Transaction History

Paulson & Co. Inc.

$1.47 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $159 Million - $186 Million	1,603,046 Added 320.61%	2,103,046 $243 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $48.2 Million - $56.2 Million	-500,000 Reduced 50.0%	500,000 $51.4 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $53.7 Million - $56.8 Million	-500,000 Reduced 33.33%	1,000,000 $109 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $287 Million - $523 Million	-4,600,000 Reduced 75.41%	1,500,000 $171 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $5.83 Million - $8.38 Million	-99,000 Reduced 1.6%	6,100,000 $378 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $46.4 Million - $68.1 Million	585,000 Added 10.42%	6,199,000 $494 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $33.4 Million - $42.4 Million	-386,000 Reduced 6.43%	5,614,000 $591 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $16.7 Million - $20.3 Million	-169,296 Reduced 2.74%	6,000,000 $647 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $167 Million - $201 Million	-1,822,144 Reduced 22.8%	6,169,296 $676 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $87.1 Million - $110 Million	1,300,001 Added 19.43%	7,991,440 $585 Million
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $11 Million - $16 Million	-200,000 Reduced 2.9%	6,691,439 $520 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $38.6 Million - $72.9 Million	-1,279,261 Reduced 15.66%	6,891,439 $383 Million
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $34.5 Million - $42 Million	1,500,000 Added 22.49%	8,170,700 $222 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $152 Million - $190 Million	6,670,700 New	6,670,700 $160 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track John Paulson's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paulson & Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Paulson & Co. Inc. and John Paulson with notifications on news.

Account